Abstract:Technological and computational advances in genomics and interactomics have made it possible to identify rapidly how disease mutations perturb interaction networks within human cells. In this study, we investigate at large-scale the effects of network perturbations caused by disease mutations within the human three-dimensional (3D), structurally-resolved macromolecular interactome. We show that disease-associated germline mutations are significantly enriched in sequences encoding protein-protein interfaces compared to mutations identified in healthy subjects from the 1000 Genomes and ExAC projects; these interface mutations correspond to protein-protein interaction (PPI)-perturbing alleles including p.Ser127Arg in PCSK9 at the PCSK9-LDLR interface. In addition, somatic missense mutations are significantly enriched in PPI interfaces compared to non-interfaces in 10,861 human exomes across 33 cancer subtypes/types from The Cancer Genome Atlas. Using a binomial statistical model, we computationally identified 470 PPIs harboring a statistically significant excess number of missense mutations at protein-protein interfaces (termed putative oncoPPIs) in pan-cancer analysis. We demonstrate that the oncoPPIs, including histone H4 complex in individual cancer types, are highly correlated with patient survival and drug resistance/sensitivity in human cancer cell lines and patient-derived xenografts. We experimentally validate the network effects of 13 oncoPPIs using a systematic binary interaction assay. We further showed that ALOX5 p.Met146Lys at the ALOX5-MAD1L1 interface and RXRA p.Ser427Phe at the RXRA-PPARG interface promote significant tumor cell growth using cell line-based functional assays, providing a functional proof-of-concept. In summary, if broadly applied, this human 3D interactome network analysis offers a powerful tool for prioritizing alleles with mutations altering PPIs that may contribute to the pathobiology of human diseases, and may offer disease-specific targets for genotype-informed therapeutic discovery.

Pathogenic mutations of human phosphorylation sites affect protein–protein interactions

Mutations in Disordered Regions Can Cause Disease by Creating Dileucine Motifs

The pathogenic T42A mutation in SHP2 rewires the interaction specificity of its N-terminal regulatory domain

Proteome-scale characterisation of motif-based interactome rewiring by disease mutations

Pathogenic mutation hotspots in protein kinase domain structure

Mapping Cryptic Phosphorylation Sites in the Human Proteome

Effects of Phosphorylation and Mutation R145G on Human Cardiac Troponin I Function.

From Mutations to Disease: Computational Analysis and Interpretation of GPCR-Associated Pathogenicity

Genome Wide Analysis of Pathogenic Sh2 Domain Mutations

Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2

Site-specific Proteasome Phosphorylation Controls Cell Proliferation and Tumorigenesis

14-3-3 phosphorylation inhibits 14-3-3θ's ability to regulate LRRK2 kinase activity and toxicity

Widespread Macromolecular Interaction Perturbations in Human Genetic Disorders

Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifs.

Deep mutational scanning of a multi-domain signaling protein reveals mechanisms of regulation and pathogenicity

Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.

Reconfiguring phosphorylation signaling by genetic polymorphisms affects cancer susceptibility.

A Systematic Exploration of the Associations Between Amino Acid Variants and Post-Translational Modifications

Mutations in Glycosyltransferases and Glycosidases: Implications for Associated Diseases

Comprehensive Characterization of Protein-Protein Interaction Network Perturbations by Human Disease Mutations

Phosphorylation and Driver Mutations in PI3Kα and PTEN Autoinhibition